Group One Trading
TEVA icon

Group One Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Group One Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-320,801
Closed -$10.3M – 8731
2025
Q4 		$10M Sell
320,801
-393,490
-55% -$9.69M 0.02% 955
2025
Q3 		$14.4M Sell
714,291
-41,910
-6% -$736K 0.03% 680
2025
Q2 		$12.7M Buy
756,201
+31,893
+4% +$515K 0.03% 664
2025
Q1 		$11.1M Sell
724,308
-771,711
-52% -$13.8M 0.03% 579
2024
Q4 		$33M Buy
1,496,019
+444,998
+42% +$8.1M 0.08% 222
2024
Q3 		$18.9M Sell
1,051,021
-1,056
-0.1% -$18.5K 0.05% 300
2024
Q2 		$17.1M Buy
1,052,077
+353,543
+51% +$5.45M 0.07% 249
2024
Q1 		$9.86M Sell
698,534
-648,893
-48% -$8.18M 0.04% 455
2023
Q4 		$14.1M Sell
1,347,427
-719,620
-35% -$6.72M 0.04% 500
2023
Q3 		$21.1M Buy
2,067,047
+351,673
+21% +$3.27M 0.07% 219
2023
Q2 		$12.9M Sell
1,715,374
-276,388
-14% -$2.24M 0.04% 401
2023
Q1 		$17.6M Sell
1,991,762
-1,403,864
-41% -$13.9M 0.06% 248
2022
Q4 		$31M Sell
3,395,626
-491,036
-13% -$4.28M 0.07% 267
2022
Q3 		$31.4M Sell
3,886,662
-624,986
-14% -$5.53M 0.06% 239
2022
Q2 		$33.9M Sell
4,511,648
-508,911
-10% -$4.43M 0.05% 290
2022
Q1 		$47.1M Sell
5,020,559
-1,049,265
-17% -$8.76M 0.05% 272
2021
Q4 		$48.6M Buy
6,069,824
+3,833,905
+171% +$34.6M 0.04% 320
2021
Q3 		$21.8M Buy
2,235,919
+261,998
+13% +$2.45M 0.02% 583
2021
Q2 		$19.5M Buy
1,973,921
+633,336
+47% +$6.7M 0.02% 644
2021
Q1 		$15.5M Sell
1,340,585
-1,624,499
-55% -$18.6M 0.02% 672
2020
Q4 		$28.6M Buy
2,965,084
+1,118,209
+61% +$10.7M 0.05% 326
2020
Q3 		$16.6M Buy
1,846,875
+415,830
+29% +$4.4M 0.05% 334
2020
Q2 		$17.6M Sell
1,431,045
-176,816
-11% -$2M 0.08% 257
2020
Q1 		$14.4M Buy
1,607,861
+1,076,195
+202% +$11M 0.12% 157
2019
Q4 		$5.21M Buy
+531,666
New +$4.75M 0.04% 664
2019
Q3 		– Sell
-333,604
Closed -$2.56M – 5545
2019
Q2 		$3.08M Buy
333,604
+89,138
+36% +$1.07M 0.03% 798
2019
Q1 		$3.83M Buy
+244,466
New +$4.31M 0.04% 564
2018
Q1 		– Sell
-73,638
Closed -$1.44M – 5300
2017
Q4 		$1.4M Sell
73,638
-425,760
-85% -$6.4M 0.01% 1443
2017
Q3 		$8.79M Sell
499,398
-80,577
-14% -$1.81M 0.08% 300
2017
Q2 		$19.3M Buy
579,975
+95,236
+20% +$2.95M 0.2% 88
2017
Q1 		$15.6M Sell
484,739
-306,656
-39% -$10.5M 0.18% 104
2016
Q4 		$28.7M Buy
791,395
+340,395
+75% +$13.6M 0.28% 57
2016
Q3 		$20.8M Buy
451,000
+156,791
+53% +$8.18M 0.23% 77
2016
Q2 		$14.8M Buy
294,209
+15,778
+6% +$840K 0.17% 100
2016
Q1 		$14.9M Buy
278,431
+81,691
+42% +$4.79M 0.21% 77
2015
Q4 		$12.9M Buy
196,740
+34,812
+21% +$2.15M 0.15% 114
2015
Q3 		$9.14M Buy
161,928
+94,682
+141% +$6.14M 0.13% 175
2015
Q2 		$3.97M Buy
67,246
+66,602
+10,342% +$4.11M 0.06% 410
2015
Q1 		$40K Buy
+644
New +$37.4K ﹤0.01% 3493

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's TEVA Position: Q1 2026 in Review

Group One Trading sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 320,801 shares — an estimated $10.3M sold.

Group One Trading first reported a position in TEVA in Q1 2015 and held it in 39 quarters. The position peaked at $48.6M in Q4 2021. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Group One Trading reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 320,801 Teva Pharmaceuticals shares in Q1 2026, an estimated $10.3M.
  • Group One Trading first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 39 quarters.
  • Group One Trading's Teva Pharmaceuticals position peaked at $48.6M in Q4 2021.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.